Edwards Lifesciences Corp. buy Royal Bank of Canada
Start price
25.07.24
/
50%
€56.76
Target price
25.07.25
€78.23
Performance (%)
-3.01%
Price
25.07.24
€55.05
Summary
This prediction is currently active. With a performance of -3.01%, the BUY prediction for Edwards Lifesciences Corp. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 25.07.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Edwards Lifesciences Corp. | -3.01% |
iShares Core DAX® | -0.612% |
iShares Nasdaq 100 | -3.018% |
iShares Nikkei 225® | -2.647% |
iShares S&P 500 | -1.932% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Royal Bank of Canada from $101.00 to $85.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€83.96
15.04.24
15.04.24
€95.04
15.04.25
15.04.25
-34.43%
25.07.24
25.07.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€80.68
07.02.24
07.02.24
€88.24
07.02.25
07.02.25
-31.77%
25.07.24
25.07.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€67.68
12.01.24
12.01.24
€74.84
12.01.25
12.01.25
-18.66%
25.07.24
25.07.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€60.38
26.10.23
26.10.23
€77.62
26.10.24
26.10.24
-8.83%
25.07.24
25.07.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€71.40
17.08.23
17.08.23
€88.14
17.08.24
17.08.24
-22.90%
25.07.24
25.07.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€74.66
01.08.23
01.08.23
€87.48
01.08.24
01.08.24
-26.27%
25.07.24
25.07.24